PHASE II STUDY OF FIXED DOSE-RATE INFUSION OF GEMCITABINE AND UFT COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED BILE DUCT CANCER: DAEGU GYEOUNGBUK ONCOLOGY GROUP

被引：0
|
作者：
Bae, S. H. [1 ]
Ryoo, H. M. [1 ]
Kim, M. K. [2 ]
Lee, K. H. [2 ]
Hyun, M. [3 ]
Do, Y. R. [4 ]
Park, K. U. [4 ]
Song, H. S. [4 ]
Kim, J. G. [5 ]
Lee, W. [6 ]
机构：
[1] Daegu Catholic Univ Hosp, Taegu, South Korea
[2] Yeungnam Univ Hosp, Taegu, South Korea
[3] Yeungnam Univ, Med Ctr, Taegu, South Korea
[4] Dongsan Med Ctr, Taegu, South Korea
[5] Kyungpook Natl Univ Hosp, Taegu, South Korea
[6] Daegu Fatima Med Ctr, Taegu, South Korea
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [1] Phase H study of fixed dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: Daegu Gyeoungbuk Oncology Group.
    Bae, S.
    Ryao, H.
    Kim, M.
    Lee, K. H.
    Kim, J.
    Do, Y.
    Song, H.
    Chae, Y.
    Lee, W.
    Baek, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Phase II study of fixed-dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: Daegu Gyeoungbuk Oncology Group
    Ryoo, H.
    Bae, S.
    Kim, M.
    Lee, K. H.
    Song, H.
    Chae, Y.
    Lee, W.
    Baek, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Fixed dose rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced biliary cancer
    Lee, S.
    Ryoo, H.
    Bae, S.
    Song, H.
    Kim, M.
    Lee, K.
    Lee, W.
    Park, K.
    Kim, J.
    Baek, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas
    Feliu, J.
    Saenz, J. Garcia
    Jaraiz, A. Rodriguez
    Castanon, C.
    Cruz, M.
    Fonseca, E.
    Lomas, M.
    Castro, J.
    Jara, C.
    Casado, E.
    Leon, A.
    Baron, M. Gonzalez
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 419 - 426
  • [5] Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas
    J. Feliu
    J. García Sáenz
    A. Rodríguez Jaráiz
    C. Castañón
    M. Cruz
    E. Fonseca
    M. Lomas
    J. Castro
    C. Jara
    E. Casado
    A. León
    M. González Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 419 - 426
  • [6] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    Feliu, J.
    Borrega, P.
    Leon, A.
    Lopez-Gomez, L.
    Lopez, M.
    Castro, J.
    Belda-Iniesta, C.
    Barriuso, J.
    Martinez, V.
    Gonzalez-Baron, M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 215 - 221
  • [7] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    J. Feliu
    P. Borrega
    A. León
    L. López-Gómez
    M. López
    J. Castro
    C. Belda-Iniesta
    J. Barriuso
    V. Martínez
    M. González-Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 215 - 221
  • [8] Phase II study of a fixed dose-rate infusion of gemcitabine associated to cisplatin and UFT in advanced carcinoma of the pancreas, an ONCOPAZ study.
    Espinosa, E
    Sáenz, JG
    Rodríguez-Jaráiz, A
    Castañon, C
    Cruz, M
    Fonseca, E
    Feliu, J
    Lomas, M
    Barón, MG
    Jara, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 338S - 338S
  • [9] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic carcinoma
    Espinosa, E.
    Feliu, J.
    de Castro, J.
    Belda, C.
    Casado, E.
    Herrero, A.
    Sereno, M.
    Pinto, A.
    Gomez, C.
    Baron, M. Gonzalez
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas
    Feliu, J
    Mel, R
    Borrega, P
    Gómez, LL
    Escudero, P
    Dorta, J
    Castro, J
    Vázquez-Estévez, SE
    Bolaños, M
    Espinosa, E
    Barón, MG
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (11) : 1756 - 1762
12345